TCRT stock

Alaunos Therapeutics Inc (TCRT) financials · rev $5.0K

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Alaunos Therapeutics Inc (TCRT) rev $5.0K.

Cached annual income statement
LineFY2025FY2024
Revenue$5.00K$10.0K
Operating Income-$4.22M-$4.81M
Net Income-$4.18M-$4.68M
EPS (Diluted)-$2.20-$2.92
Cached annual balance sheet
LineFY2025FY2024
Total Assets$2.97M$2.75M
Current Assets$1.99M$2.75M
Cash & Equivalents$1.39M$1.09M
PP&E$91.0KN/A
Total Liabilities$813.0K$692.0K
Current Liabilities$813.0K$692.0K
Long-term DebtN/AN/A
Shareholders' Equity$2.15M$2.06M
Retained Earnings-$924.6M-$920.4M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$2.87M-$4.97M
CapEx$98.0KN/A
Investing Cash Flow-$98.0KN/A
Financing Cash Flow$3.26MN/A
Net Change in Cash$294.0K-$4.97M
Free Cash Flow-$2.97M-$4.97M
These statements as JSON? API free 100/day

FAQ

What is TCRT P/E and revenue?

Alaunos Therapeutics Inc (TCRT) rev $5.0K.

What is TCRT revenue?

Alaunos Therapeutics Inc last cached revenue is $5.00K (FY2025).

Is TCRT profitable?

Alaunos Therapeutics Inc last cached net income is -$4.18M (FY2025).

What are TCRT total assets?

Alaunos Therapeutics Inc last cached total assets are $2.97M (FY2025).

What is TCRT free cash flow?

Alaunos Therapeutics Inc last cached free cash flow is -$2.97M (FY2025).

Not investment advice. Cached statements, not a live tape.